Business ❯Pharmaceuticals ❯AstraZeneca ❯Financial Performance

Revenue Growth

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe

AstraZeneca Faces Turmoil Amid Chinese Investigations

AstraZeneca Projects Strong Growth in 2024 Despite COVID-19 Sales Dip